 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter A - General |
|
|
Subpart C - “Framework” Provisions |
| § 26.60 - Definitions. |
| § 26.61 - Purpose of this part. |
| § 26.62 - General obligations. |
| § 26.63 - General coverage of this part. |
| § 26.64 - Transitional arrangements. |
| § 26.65 - Designating authorities. |
| § 26.66 - Designation and listing procedures. |
| § 26.67 - Suspension of listed conformity assessment bodies. |
| § 26.68 - Withdrawal of listed conformity assessment bodies. |
| § 26.69 - Monitoring of conformity assessment bodies. |
| § 26.70 - Conformity assessment bodies. |
| § 26.71 - Exchange of information. |
| § 26.72 - Sectoral contact points. |
| § 26.73 - Joint Committee. |
| § 26.74 - Preservation of regulatory authority. |
| § 26.75 - Suspension of recognition obligations. |
| § 26.76 - Confidentiality. |
| § 26.77 - Fees. |
| § 26.78 - Agreements with other countries. |
| § 26.79 - Territorial application. |
| § 26.80 - Entry into force, amendment, and termination. |
| § 26.81 - Final provisions. |